BETA-INTERFERON-1b (Betaferon®)

Clinical Indication

Multiple sclerosis in adults


In line with NICE TA 527

Date of classification

August 2018


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.